Follow-Up of Cancer Patients Receiving Anti-PD-(L)1 Therapy Using an Electronic Patient-Reported Outcomes Tool (KISS): Prospective Feasibility Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) have become a standard of care for various tumor types. Their unique spectrum of side effects demands continuous and long-lasting assessment of symptoms. Electronic patient-reported outcome (ePRO) follow-up has been shown to improve survival and qualit...

Descripción completa

Detalles Bibliográficos
Autores principales: Iivanainen, Sanna, Alanko, Tuomo, Vihinen, Pia, Konkola, Teemu, Ekstrom, Jussi, Virtanen, Henri, Koivunen, Jussi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2020
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657724/
https://www.ncbi.nlm.nih.gov/pubmed/33112242
http://dx.doi.org/10.2196/17898

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7657724/
https://www.ncbi.nlm.nih.gov/pubmed/33112242
http://dx.doi.org/10.2196/17898

Ejemplares similares